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Resumo 
  
 A Endoderme Definitiva (DE) é uma das três camadas germinativas formadas 
durante a gastrulação e origina o tubo digestivo primitivo e os orgãos a este 
associados. Durante o desenvolvimento, cada região do tudo digestivo primitivo é 
caracterizada por motivos de expressão distintos que determinam a localização exacta 
onde os diferentes orgãos deverão surgir ao longo do eixo antero-posterior. Ao mesmo 
tempo, o tubo digestivo primitivo também é especificado ao longo to eixo dorso-ventral, 
e a maioria dos orgãos surgem ventralmente. O mecanismo que leva à formação do 
eixo dorso-ventral no tubo digestivo primitivo é ainda mal compreendido. No tubo 
neural este processo foi extensivamente estudado e é descrito como um equilibro 
entre a expressão de Bone Morphogenetic Protein (BMP)4 - dorsalmente - e de Sonic 
Hedgehog (SHH) - ventralmente. Para além disso, diversos estudos indicam que 
sinalização pela BMP é necessária para a formação de alguns orgãos ventrais 
associados ao tubo digestivo primitivo. Tendo isto em conta, propomos que a via de 
sinalização da BMP poderá ser responsável por conferir identidade ventral ao tubo 
digestivo.  
 Neste projecto, caracterizamos um ratinho mutante previamente gerado pelo 
nosso grupo, em que CreERT2 é expressa sobre o controlo do promotor de Sox17. Este 
fator de transcrição é expresso na DE antes da formação do tubo digestivo primitivo. 
Após a caracterização, o ratinho foi utilizado para inativar condicionalmente a via de 
sinalização da BMP no tubo digestivo, através de inativação dos receptores principais 
da BMP. Os resultados preliminares estão geralmente de acordo com outros estudos 
que se focaram no papel da BMP na formação do tubo digestivo e orgão adjacentes. 
Para além disso, os resultados sugerem que a via de sinalização da BMP é essencial 
para a formação de orgãos ventrais como os pulmões e o primórdio pancreático 
ventral, algo que não foi previamente descrito. 
 
 
Palavras chave: Endoderme definitiva, eixo dorso-ventral, BMP, Sox17  
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Abstract 
  
 The definitive endoderm (DE) is one of three germ layers segregated during 
gastrulation and it gives rise to the primitive gut tube and all associated organs. During 
development, each region of the primitive gut tube is characterized by unique 
expression patterns that determine the precise locations where organs emerge along 
the anterior-posterior axis. At the same time, the primitive gut is also patterned along 
the dorsal-ventral axis, with most organs emerging on the ventral side of the gut. 
Dorsal-ventral patterning is still poorly understood in the gut tube. In the neural tube, 
dorsal-ventral patterning is well described as a balance between expression of Bone 
Morphogenetic Protein (BMP)4 - dorsally - and Sonic Hedgehog (SHH) - ventrally. 
Furthermore, several distinct studies indicate that BMP is required in the formation of 
some of the ventral gut organs. Taking this into consideration, we theorized that BMP 
signalling could be a general cue providing ventral identity to the gut tube.  
 In this study, a mouse line previously generated by our group is characterized in 
which CreERT2 is expressed under the control of the promoter of Sox17. This 
transcription factor is expressed in definitive endoderm cells at a very early stage, 
previous to primitive gut formation. Thereafter, this mouse line is used as a tool in order 
to conditionally inactivate the BMP pathway in the DE, by knocking out its main 
receptors. Preliminary data are generally in accordance with previous observations 
made for the role of BMP in gut patterning and organ formation. Furthermore, we find 
BMP signalling to be essential for the formation of ventral organs like the lungs and the 
ventral pancreas, which had not been reported previously.  
 
 
Key words: Definitive endoderm, Patterning, BMP, Sox17 
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Figure 1.1. Gastrulating mouse embryo. The embryo is 
enveloped by the VE which is divided into extraembyonic 
(ExVE, white) and embryonic (EmVE, yellow and green). 
The ExVE gives rise to the yolk sac while the EmVE may 
take part in gut tube formation. The extraembryonic 
ectoderm (ExE, grey) locates proximally and the epiblast 
distally. The epiblast is constituted by prospective 
ectoderm (blue), mesoderm (red) and endoderm (green). 
The primitive streak locates in the posterior region of the 
epiblast. Orange - prechordal plate; Light grey - 
extraembryonic mesoderm.       
Introduction 
 
 The ability to generate specific cell types that can develop into tissues or even 
functional organs holds the promise to treat a long array of health issues while 
eliminating some of the major problems currently associated with organ transplantation. 
Currently, engineered tissues are also being used to generate models for drug testing 
or for studying disease emergence and progression6,7. Organ formation is 
characterized by a vast intricacy in signalling pathways and architecture that is difficult 
to replicate. In order to efficiently recapitulate tissue and organ development in vitro, we 
must first understand how specific signalling pathways orchestrate organogenesis in 
vivo, by studying the developing embryo. 
 In this study, we aim at understanding the general principles that lead to the 
formation of different organs from the endoderm, focusing on the role of the BMP 
pathway. 
 
 1.1. Formation of the Primitive Gut Tube 
 The organism is derived from three primary germ layers. The ectoderm gives 
rise to the epidermis and the nervous system8; the mesoderm differentiates into 
connective tissues, the muscles, the vasculature and the hematopoietic system9; the 
definitive endoderm (DE), also called endoderm, forms the digestive tract and 
respiratory system, as well as their associated organs5. The three germ layers are 
specified during gastrulation, which starts at around 6 days and a half post-fertilization 
(E6.5) in mice. At this point, the embryo comprises a bilaminar cup-shaped epithelium 
where an outer visceral endoderm (VE) layer encapsulates the proximally positioned 
extraembryonic ectoderm (ExE), and the distally positioned epiblast that will go on to 
form the actual embryo (Figure 1.1). 
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Figure 1.2. Gut tube closure and turning. Endodermal, mesodermal and 
ectodermal layers are respectively shown in yellow, red and blue. Mouse 
embryos (E8.0, 8.5 and 9.0) are pictured. In mouse, a crescent-shaped fold 
appears in the endoderm at the level of the tip of the neural tube and moves 
posteriorly (AIP) as indicated by arrows. A similar fold later arises at the very 
posterior end of the embryo and moves anteriorly (CIP). Convergence of these 
folds is facilitated by the turning of the embryo (big arrows). A - anterior; P - 
posterior; D - dorsal; V - ventral. 
Gastrulation starts when epiblast cells ingress locally in the posterior region of the 
epiblast - the primitive streak - emerging as nascent mesoderm. The newly formed 
mesenchymal layer locates between the inner epiblast cells and the outer visceral 
endoderm (VE). The last cell population to emerge from the primitive streak constitutes 
the DE (reviewed in Nowotschin and Hadjantonakis 10). Early cell labelling studies, 
combined with molecular marker analysis indicated that DE cells displace the VE cells 
into the extraembryonic domain, where these form the yolk sac. However, recent 
studies suggest that some VE cells persist in the DE layer and even participate in 
primitive gut tube formation11,12. 
 At the end of gastrulation, the DE constitutes a sheet of cells on the external 
surface of the mouse embryo. Over the next 24 hours embryonic tissues are 
rearranged forming the primitive gut tube, surrounded by the mesoderm. The 
movements involve the invagination of the DE in two different sites, one anterior at the 
anterior intestinal portal (AIP) and one posterior at the caudal intestinal portal (CIP) 
forming two dead end tubes which thereafter extend 
caudally and rostrally, respectively, meeting in the midgut 
region. During this process the cells on the lateral sides of 
the DE migrate toward the ventral midline of the gut tube 
while the medial part of the DE roughly forms the dorsal 
wall of the primitive gut tube. The closure of the primitive 
gut tube is associated with axial turning, which gives to the 
embryo its characteristic fetal shape (Figure 1.2). 
 
 1.2. Patterning of the Primitive Gut Tube  
 While the gut tube is closing, regions of the gut are specified along the anterior-
posterior (AP) axis into the different DE-derived organs. The rigorous organization 
pattern along the AP axis is orchestrated by reciprocal inductive signals between the 
endoderm and the surrounding mesoderm. Initially, broad domains can be identified by 
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expression of Hhex, Sox2, and Foxa2 transcription factors in the anterior half of the 
embryo opposed to the expression of Cdx1, Cdx2, and Cdx4 in the posterior half. 
These transcription factors are critical for regional foregut and hindgut identity, 
respectively. Already at this stage the two domains show distinct developmental 
potential and respond differently to subsequent signalling from the mesoderm. For 
example, graded levels of FGF signalling from the anterior foregut induce distinct fates. 
The highest levels induce the expression of Nkx2.1 in the future lung and thyroid 
progenitors, moderate doses activate liver progenitor fate, and lower levels promote the 
expression of Pdx1 specifying the pancreas and the duodenum. BMP activity is also 
present as a decreasing signal from the anterior side of the embryo. The effect of BMP 
signalling on gut patterning will be reviewed in the next sections. Eventually, these 
defined territories undergo morphogenesis, resulting in complex organs (reviewed in 
Zorn and Wells 5). 
 The primitive gut tube is also patterned along the dorsal-ventral (DV) axis. Most 
organs emerge on the ventral side of the gut, with the exception of the dorsal pancreas 
and the parathyroids13,14. However, it is not known if general dorsalizing or ventralizing 
morphogens exist in mammals, although BMP4 has been shown to have a ventralizing 
effect in Xenopus animal cap15.  
 
 1.3. BMP Signalling 
  BMPs were first identified for their capacity to induce ectopic bone formation16. 
Since then, they have been shown to be involved in pleiotropic morphogenetic 
processes (reviewed in Wagner, et al. 17). Similarly to other members of the TGFβ 
superfamily, BMPs are large dimeric proteins synthesized and folded in the cytoplasm 
as inactive precursors. After being activated by proteolytic cleavage (e.g. Furin is 
required for BMP4 activity18), their functional C-terminal part is released into the 
extracellular compartment where it can signal to target cells by binding to receptor 
subunits Type I and Type II serine/threonine protein-kinase. Once the multimeric 
complex is formed, Type II receptors transphosphorylate Type I receptors which in turn 
phosphorylate the downstream receptor regulated R-Smad proteins - Smad1, Smad5, 
Smad8. Phosphorylated R-Smads associate with the co-mediator Smad4 and migrate 
to the nucleus, where they activate the expression of their target genes19,20 (Figure 
1.3). 
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Figure 1.3. Cascade of BMP 
signalling. BMP dimers bind to 
serine/threonine kinase receptors 
type I and II. Upon ligand binding, 
type II receptors transphos-
phorylate type I receptors. The 
latter phosphorylate members of 
the Smad family of transcription 
factors. These Smads are 
subsequently translocated to the 
nucleus, where they activate 
transcription of target genes. 
 
  
 
 More than 30 ligands are able to activate BMP signalling. They are structurally 
related and can be further subdivided into subgroups. Two of them, Bmp2 and Bmp4, 
diverged from a common ancestral gene and encode closely related proteins21.  
 Bmp4 and Bmp2 are both expressed in the extraembryonic tissues, although 
Bmp2 expression is predominant. In the embryo, Bmp2 is strongly expressed in the 
cardiac crescent at E7.25. Like Bmp2, Bmp4 expression is observed in the heart but it 
is restricted to the inflow and outflow tracts. Both are expressed at E9.0 in the dorsal 
neural tube. During the gut tube closure at E7.25, Bmp2 is strongly expressed in the 
closing anterior gut tube, while being notably absent from the open gut region. 
Thereafter, Bmp2 is almost undetectable in the midgut and the foregut at the exception 
of the liver primordium at E9.0. On the contrary Bmp4 is expressed in the thyroid 
primordium. At E10.5, Bmp4 is also strongly expressed in the lung bud mesenchyme 
and on the right dorsal side of the gut tube, along the stomach and pancreas22. 
Although both ligands show some functional redundancy, knocking out one or the other 
leads to different phenotypes. Bmp4 null embryos phenotype is background 
dependant. The formation of the mesoderm may be severely impaired due a 
gastrulation defect and the embryos die at the start of gastrulation (E6.5), whereas 
other mouse strains survive until early organogenesis (E9.5)23. On the contrary, Bmp2 
knockout mice are able to gastrulate, they die at around E8.5 due to amnion/chorion or 
heart development defects24. 
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 1.4. Bmp receptors: Alk2, Alk3 and Alk6 
 The abundance of ligands in the BMP family is not matched by similar numbers 
of receptors. Thus the BMP pathway has highly promiscuous ligand-receptor 
interactions. Two Type I receptors - BMPR1A;ALK3 and BMPR1B;ALK6 - are known to 
translate signals from BMP2/421. BMP4 has also been reported to bind to Type I A 
activin receptor ActR-I;ALK2 in the visceral endoderm (VE), although this pathway 
leads only to the activation of SMAD1/5 and not SMAD825. This difference in the 
activation pattern of R-Smads by ALK3 and ALK6 or ALK2 is translated into distinct 
biological responses26.  
 In contrast to the localized expression patterns of BMP ligands, expression of 
BMP receptors is widespread during early embryonic mouse development. Alk3 and 
BmpRII are expressed in most tissues throughout development. Alk6 expression starts 
later during development, after the gastrula stage. It is first observed at E7.5 in the AIP 
and is later expressed along the endoderm and in the liver primordium at E9.0. This 
expression pattern is maintained until E10.5, albeit at lower levels22,27. Alk2 is 
expressed in pre-gastrulating and gastrulating embryos, mostly in extra-embryonic 
tissues (VE, chorion, amnion), and later, at E10.5, it is expressed in the head 
mesoderm as well as in the endocardium28. 
 Mice lacking Alk6 show only mild skeletal defects in the adult29. However, 
mouse embryos lacking Bmp4, Alk3, or BmprII are arrested at gastrulation, and 
mesoderm does not form23,30,31. 
 
 1.5. BMP signalling in patterning of the gut tube 
 Very little is known about how the DE-derived organs acquire their positions 
along the DV axis in mammals. During organ specification when the DE still forms a 
sheet, the morphogens giving this information, if any, should first be positioned along 
the medio-lateral axis and after, the gut tub is closed, along the DV axis. Contrary to 
the endoderm, this process is well characterized in the ectoderm and seems to be a 
conserved system across vertebrates and insects, where antagonistic secreted factors 
determine first medial or lateral identity and later dorsal or ventral identity. For example, 
BMP4 orthologs found in fly and in vertebrates share similar functions and mechanisms 
for medio-lateral and later DV patterning in the ectoderm32. In mice, opposing gradients 
of sonic hedgehog (SHH) and bone morphogenetic protein (BMP) signalling are 
involved. BMP signalling is necessary to form laterally the non-neural ectoderm or 
surface ectoderm which becomes thereafter located dorsally in the neural tube. After 
FCUP 
Role of the BMP Pathway in Definitive Endoderm Patterning 
12 
 
 
 
the neural tube is closed, the roof plate situated dorsally becomes a new organizing 
centre that produces BMPs which induce a dorsal fate in the  interneurons present in 
the dorsal side of the neural tube (reviewed in Liu and Niswander 33). 
 In the endoderm, several studies describe a role of BMP in the formation of 
some ventral organs all along the anterior-posterior axis (Figure 1.4). The thymus, 
which emerges on the ventral domain of the thymus-parathyroid primordium, is 
severely reduced when BMP signalling is inhibited by Noggin, an antagonist of BMP. 
Besides, it does not reach its final destination in the mediastinum34. Conversely, the 
presence of BMP4 in the dorsal domain where the parathyroid originates, reduces the 
expression of the parathyroid specific marker Gcm235. BMP4 is necessary for the 
formation of the trachea in the ventral foregut 36. The oesophagus does not form in 
absence of Noggin, a BMP antagonist. If BMP signalling is disrupted after lung 
specification, lung development is delayed and less branches are formed 37In the 
absence of BMP4, the liver development is also delayed. In E9.5 mutant embryos, the 
hepatic epithelium did not yet bud contrary to their WT littermates 38. Moreover, in vitro 
specification of hepatocytes from ESC-derived DE cells requires the presence of 
BMP439. More globally, Xenopus ectodermal explants adopt a ventrolateral endodermal 
fate when Bmp4 is overexpressed 15. 
 
  
 These observations prompt the hypothesis that in mouse BMP signalling is a 
global cue that initially induces lateral identity to the DE and after gut tub closure, 
ventral identity forming a mirror-image of ectodermal and neural tube patterning. For 
the DE, BMPs secreted by the mesoderm would induce cell fate in the lateral regions of 
the DE which progressively join at the midline to form a tube. After gut closure, BMP 
Figure 1.4. Primitive gut and associated organs. At E10.5 all organs associated to the gut tube have started to 
develop with a strict organization along the AP and DV axis.  
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Figure 1.5. Mirror DV patterning in the neural tube and the gut tube. A. BMP is expressed in the lateral mesoderm 
(red) and secreted and patterns lateral ectoderm, while SHH secreted by the notochord (red dot) patterns medial 
ectoderm (blue). B. During the dorsal folding of the neural tube, the lateral ectoderm becomes the dorsal non-neural 
ectoderm (skin) and medial ectoderm forms the neural tube. In the neural tube, BMP starts being secreted in the roof 
plate (yellow) and patterns the dorsal region of the neural tube, opposed by SHH in the ventral region. We hypothesize 
that concurrently, BMP secreted in the mesoderm patterns lateral DE (orange) while SHH secreted in the notochord 
may pattern medial DE. C. The gut tube folds in a mirror image to the neural tube and thus lateral tissues end-up 
ventrally in the tube.  After ventral closure, SHH secreted by the notochord may pattern the dorsal region of the primitive 
gut tube and BMP secreted in the mesoderm may pattern the ventral region. BMP secretion may form a medio-lateral 
and later dorsal-ventral gradient. Black arrows - BMP signalling; Blue arrows - neural tube closure; Orange arrows - gut 
tube closure. D - Dorsal; V - Ventral; M - Medial; L - Lateral. 
would act on the ventral side of the tube. Therefore, BMP signalling would be required 
for the ventral identity of the gut (Figure1.5). 
 
 
  
 However, the requirement of BMP signalling during gastrulation precludes 
further study during endoderm patterning. In order to explore the role of BMP in DV 
patterning of the gut tube, a time and tissue specific inactivation of the pathway is 
necessary. For example, in the respiratory tract, conditional inactivation of the BMP 
pathway was previously achieved by inactivating its two well characterized receptors - 
Alk3 and Alk6 in the future lung epithelium after organ specification37. Our aim was to 
inactivate it in the endoderm.  
 
 1.6. Sox17 Expression 
 The SRY (sex determing region Y)-box 17 (SOX17) is a transcription factor 
belonging to the Sox protein family. Sox proteins share similar DNA binding properties, 
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however individual Sox proteins appear to regulate specific sets of target genes in vivo 
due to restricted patterns of expression and in combination with specific cofactors 
interactions. Sox proteins are key players in the regulation of embryonic development 
and determination of cell fate (reviewed in Lefebvre, et al. 40).  
 SOX17 is first expressed at the blastocyst stage between E3.25 and E4.5, in a 
salt and pepper pattern, where it promotes the primitive endoderm cell fate over the 
epiblast fate41. Subsequently, it is also expressed in the visceral endoderm around 
E6.0-E6.5 42. SOX17 is dynamically expressed in the DE, forming a temporal and 
spatial wave of expression from the anterior to the posterior region of this tissue. At 
first, expression is detected in the anterior end of the primitive streak at E7.0, which 
coincides with the time of ingression of future anterior DE cells. By E8.0 SOX17 is 
observed in the prospective posterior gut, while its expression in the foregut is already 
reduced. Its expression in the hindgut shuts down around E9.0. SOX17 is a key player 
in the definitive endoderm development as it is necessary for its specification42,43. After 
E9.0, SOX17 expression is observed in the hemogenic endothelial cells (ECs), which 
are of mesodermal origin44. SOX17 is then necessary for definitive hematopoiesis and 
the maintenance of the hematopoietic stem cell pool, both at the fetal and neonatal 
stages1,45. Notably, at around E9.5, SOX17 is again expressed in the ventrolateral 
region of the most posterior foregut, where the bile duct and gall bladder originate, and 
persists until at least E15.546. Based on this expression pattern, it appears that Sox17 
may be used as a driver to target gene inactivation widely in endoderm. 
 
 1.7. The Cre Recombinase System  
 Cre (cyclization recombination) gene encodes a site-specific DNA recombinase 
of the bacteriophage P1 which is required for the circularisation of the phage DNA - a 
critical step in the bacteriophage life-cycle. The enzyme recognizes a specific 
sequence of 34-bp, termed loxP, and catalyses both intra and intermolecular 
recombination between two loxP sites. Cre–loxP mediated recombination between two 
directly repeated loxP sites excises all DNA sequences located within the two sites as 
a covalently bound circular molecule47. 
 The conditional deletion of a gene in mice (conditional knock-out) is achieved by 
excising with a Cre the gene flanked by two LoxP sites, also called floxed gene. The 
gene promoter driving Cre expression determines tissue or stage specificity. Temporal 
control of the onset of the mutation can be further achieved by using a Cre fused to a 
modified Estrogen Receptor (ERT2). CreERT2 is sequestered in the cytoplasm unless 
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tamoxifen, an estrogen analogue, is present and has been metabolically activated in 
the liver48.  
 Sox17 promoter has already been used to drive the expression of Cre 
recombinase in the endoderm and in the hemogenic endothelial cells1,49. As it is 
specifically expressed in the DE cells at a particular stage of development, it is possible 
to target these cells using a CreERT2 system. This strategy has already been 
confirmed by generating a Sox17CreERT2 mouse line50. 
 Another Sox17CreERT2 line has contemporarily been developed in our laboratory. 
The Cre recombinase fused to an estrogen receptor has been targeted to the Sox17 
locus disrupting the gene after the second exon, in contrast to the previously published 
line (Figure 1.6) (Marine Rentler-Courdier-Kraus, unpublished data).  
 
 
 
Figure 1.6. Diagram of the Sox17 locus, targeting vector, Sox17LCA allele, CreERT2 exchange cassette, 
Sox17GFPCre(þHygroR), and Sox17CreERT2 allele. A targeting vector for the mouse Sox17 gene was 
constructed where the sequence including exons 3–5, which contains the coding region of Sox17, was replaced 
with a puromycin resistance-D-thymidine kinase fusion gene (puDTK) and an EM7-driven kanamycin resistance 
gene (KanR) flanked by lox66 (open triangle) and lox2272 (black triangle) sites. The GFPCre exchange cassette 
was flanked by lox71 (gray triangle) and lox2272 sites and contained a phosphoglycerol kinase-driven hygromycin 
resistance gene (HygroR) flanked by flippase recognition target sites (open circles). This prepares the locus to easy 
replacement by any insertion and was previously used to insert a CreGFP fusion1. Following exchange into 
Sox17LCA-containing mouse embryonic stem cells by recombinase-mediated cassette exchange (RMCE), mice 
containing the Sox17CreERT2-(þHygroR) allele, were bred with FLPe-expressing transgenic mice, thereby 
generating the final Sox17CreERT2 allele. Abbreviations: DT-A, Diphtheria toxin A; LA, long arm; LCA, loxed 
cassette acceptor; SA, short arm. 
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 1.8. General Aims and Strategy 
 Prior evidence suggests a role of the BMP pathway in the formation of several 
ventral endodermal organs. We hypothesised that BMP signalling acts as global 
ventralizing factor in the gut, mirroring its action in the neural tube where it is necessary 
for dorsal identity (Figure 1.3). 
 In the present study, we characterized the Sox17CreERT2 mouse line that was 
previously generated in our lab in order to determine the most reliable way to induce 
recombination in the DE without affecting the other tissues.  
The newly characterized mouse line was then used to inactivate the BMP signalling 
pathway in the DE by deleting Alk3 using the Sox17CreERT2, in an Alk6 null background. 
The outcome of the inactivation has been thoroughly analysed by whole mount 
imaging. For this purpose, efficient labelling of dorsal and ventral endoderm organ 
primordia was established. 
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Materials and Methods 
 
2.1. Mouse breeding and genotyping 
 The Sox17CreERT2 allele was maintained within an ICR background for 
experiments. Mice with the Rosa26YFP, Alk3flox or Alk6- allele were previously 
described29,30,51 . The mating scheme used in order to obtain BMP pathway mutants is 
described in Table 2.1, along with the ratios of each genotype obtained in the progeny 
and the designations attributed for simplicity. Mice were housed at the University of 
Copenhagen. The Dyreforsøgstilsynet approved the mouse housing and experiments. 
 Midnight before a vaginal plug was observed was considered as the time of 
fertilization (E0). Pregnant females received an intraperitoneal injection of warmed 
tamoxifen (Sigma) dissolved in corn oil at a concentration of 10mg/mL, with a 25 gauge 
needle. Each female was weighed before injection and the volume of injected 
tamoxifen was calculated accordingly. To collect the embryos at the different time 
points (E9.5, E10.5, E12.5), the females were euthanized by cervical dislocation and 
the embryos were dissected out of the uterus in PBS. A part of the yolk sac was 
removed and used for genotyping. The embryos were fixed in PFA 4% (Sigma) for 2 
hours on ice with shaking.   
 
Table 2.1. Breeding scheme for BMP mutants 
Parent 2 Alleles Parent 1 Alleles 
Alk3fl Alk6 + Sox17 + Alk3fl Alk6 - Sox17 + 
Alk3fl Alk6+ Sox17CreERT2 
 
Alk3fl/fl Alk6+/+ Sox17CreERT2/+ 
 
Alk3fl/fl Alk6+/- Sox17CreERT2/+ 
1/8 1/4 
Alk3 KO Hz 
   
Alk3fl Alk6- Sox17CreERT2 
Alk3fl/fl Alk6+/- Sox17CreERT2/+ Alk3fl/fl Alk6-/- Sox17CreERT2/+ 
1/4 1/8 
Hz dKO 
   
Alk3fl Alk6+ Sox17+ 
Alk3fl/fl Alk6+/+ Sox17+/+ Alk3fl/fl Alk6+/- Sox17+/+ 
1/8 1/4 
WT Alk6 +/- 
Alk3fl Alk6- Sox17+ 
 
Alk3fl/fl Alk6+/- Sox17+/+ 
 
Alk3fl/fl Alk6-/- Sox17+/+ 
1/4 1/8 
Alk6 +/- Alk6 KO 
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 PCR genotyping was performed on tail tip genomic DNA and embryonic tissue 
after lysis in 100µL PCR direct tail buffer (Viagen) containing 2,5µL 20,6 mg/mL 
Proteinase K (Roche) overnight at 55ºC, followed by Proteinase K heat inactivation for 
45 min at 85ºC. Each PCR reaction contained 2 to 4 µL of genomic DNA digestion 
solution, 5 µL of 5x Green GoTaq buffer (Promega), 1 µL of 5mM dNTPs (Thermo 
Fisher Scientific), 1 µL of 10 µM primer stock (Table 2.1), 0,2 µL of 5u/µL GoTaq 
enzyme (Promega) and miliQ to a final volume of 25 µL. All primers were ordered from 
Integrated DNA Technologies.   
 
Table 2.2 Genotyping Primers 
Locus Primers 
Annealing 
temperature 
Cº 
product size 
WT mutant 
Sox17 5'-TGCCAC GACCAAGTGACAGC-3' 58 no product 700 5'-CCAGGTTACGATAT AGTTCATG-3' 
Rosa26 
5'- AAAGTCGCTCTGAGTTGTTAT-3 
58 600 300 5'-GCGAAGAGTTTGTCC TCAACC-3' 
5'-GGAGCGGG AGAAATGGATATG-3' 
Alk3 
5'-GCAGCTG CTGCTGCAGCCTCC -3' 
50 350 600 
5'-TGGCTACAATTTGTCT CATGC-3' 
Alk6 
5'-CCCAAGATCCTACGT TGTAA-3' 
62 150 230 5'-GAGTGGTTACAACAAGATC AGC A-3' 
5'-GCCCTGAATG AACTGCA GG-3' 
 
 Electrophoresis gels were prepared with 2% ultra pure agarose (Thermo Fisher 
Sci.) in TAE 1x (in house) containing 0,003% ethidium bromide (Thermo Fisher Sci.). In 
each well, 6 µL of the PCR reaction was loaded as well as a 1kb DNA ladder 
(Thermofisher Scientific). The gels were submitted to 80mV voltage on a standard 
power pack p25 (Biometra) for roughly 20 min and imaged with a molecular imager 
(GelDoc XR+, BioRad). 
 
2.2. Immunofluorescence 
2.2.1. Immunofluorescence on sections - General protocol 
 Fixed embryos were thoroughly washed with PBS (1.8 mM KH2PO4, 10 mM 
Na2HPO4, 137 mM NaCl, 2.7 mM KCl pH7.4)a and incubated in a solution of 0.12M 
                                                
 
a Steps where the temperature is not mentioned were performed at room temperature. 
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phosphate buffer 15% sucrose (Merck) (sucrose) overnight at 4ºC for cryoprotection. 
Fresh sucrose solution was added for 30 min, followed by 0.12M phosphate buffer 15% 
sucrose 7.5% gelatin (Sigma) (gelatin) at 38ºC for 30 min. The embryos were embeded 
in a gelatin block and the block set at 4ºC for 15 min. The gelatin blocks were then 
unmolded. They were frozen at -65ºC for 1 min. The blocks were stored at -80ºC until 
use. Sections of 7μm thickness were obtained using a cryostat (CM1959 Leica) at -
24ºC. The cryosections were stored at -20ºC on Superfrost Plus Slides slides 
(ThermoFisher). The general protocol forimmunofluorescence on sections 
consisted of a drying step of 5 min , followed by rehydration with tris buffer (50 mM Tris 
pH 7.5, 150 mM NaCl) 0,01% triton (TBST), permeabilization with tris buffer 0,25% 
triton (Applichem), washing with TBST 3x5 min and blocking with 10% donkey serum 
(Sigma) in TBST for 1 hour. All primary antibodies (see Table 2.1) were diluted in 
blocking solution and the sections covered by the antibody solution were incubated 
overnight at 4ºC. The sections were then washed with TBST 3x15 min and the 
respective secondary antibodies (See table 2.2) were diluted in blocking solution and 
centrifuged for 10 min at 21000 rcf, at 4ºC. Secondary antibodies and DAPI (Sigma) 
were incubated for an hour, after which the slides were again washed with TBST 3x15 
min. The slides were mounted with 50% glycerol (Sigma) solution in PBS and kept at 
4ºC until imaging. All images were acquired with either a wide field (DM5500B, Leica) 
or a confocal (LSM 780, Zeiss) microscope.  
 
2.2.2. Antigen Retrieval 
  In some cases, antigen retrieval was performed after the washes 
following the permeabilization steps. The slides were equilibrated for 5 min in 10mM 
trisodium citrate buffer pH6 and warmed gradually from 65ºC to 95ºC in an automated 
epitope recovery device (PT module, Lab vision). This temperature was maintained for 
20 min after which it went down to 65ºC.The slides were then washed 3x5 min with 
TBST and the rest of the immunofluorescence was carried out as usual. 
  
2.2.3. Antibody Stripping 
 Antibody stripping was performed in order to allow sequential staining with two 
antibodies derived from the same species. After the first immunofluorescence, the 
sections were washed in TBST and incubated for 1 hour at 60 ºC in a solution of 62,5 
mM Tris-HCl (Sigma), 2% SDS (Sigma) and 0,8% β-mercaptoethanol (Sigma)52. The 
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slides were then washed extensively in running tap water for 10 min, rinsed in 95% 
ethanol (Merck) followed by milliQ water and by TBST. The general protocol was 
continued from this step on. When Tyramide Signal Amplification kit (Thermo Fisher 
Sci.) is used in the first round of staining, both antibody stainings can be imaged at the 
same time. 
 
1.2.4. Phosphatase Assay 
 In order to ensure specificity of the pSMAD1/5/8 antibody to the phosphorylated 
form of this protein a phosphatase assay was performed. After permeabilization and 
washes in TBST, the sections were washed 2x2 min in milliQ water and rinsed in 
TBST. Each slide was treated with a solution of Lambda Phosphatase (New England 
Biolabs) prepared according to the manufacturer's instructions, for 2 hours at 37ºC. 
After the treatment, the slides were washed 2x5 min in milliQ water followed by 5 min in 
TBST. The general protocol was carried on from this point. 
 
1.2.5. Wholemount Immunofluorescence 
 Fixed embryos were thoroughly washed with PBS and gradually dehydrated to 
Methanol (Sigma) with sequential dilutions (50%Methanol in PBS, 100%Methanol in 
PBS) for at least 15 min each. These embryos were stored at -20ºC. 
 The embryos were incubated in a solution of 16% DMSO (Sigma) and 5% H2O2 
(Sigma) in methanol overnight at 4ºC. The samples were rehydrated to PBST. Blocking 
solution - PBS 0,5% Tween (Sigma) (PBST) containing 1%BSA (Roche) - was added 
and incubated for 8 hours or overnight. Primary antibodies were diluted in blocking 
solution and incubated for 40 to 48 hours at 4ºC. Primary antibodies were washed with 
PBST extensively all day or overnight at 4ºC and secondary antibodies were added 
diluted in blocking solution and incubated for 40 to 48 hours at 4ºC. Secondary 
antibodies were washed with PBST extensively all day or overnight at 4ºC and finally 
the samples were gradually dehydrated to methanol with sequential solutions 
(Methanol 50%, 100%) for at least 15 min each. All steps of the protocol were carried 
out over mild agitation using a rocking platform. These samples were stored at -20ºC 
until imaging. Before imaging by confocal microscopy, samples were cleared in 33% 
Benzyl Alcohol (Merck) 66% Benzyl Benzoate (Merck) (BABB) overnight and mounted 
in depression slides. All wholemount immunofluorescence samples were scanned on a 
confocal (SP8, Leica) microscope. After imaging, samples were again stored in 
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methanol at -20ºC, until further experiments. All image processing and analysis was 
performed on Imaris 8.1 software.  
 
Table 2.3. Primary Antibodies 
Targeted antigen Origin Sections Wholemount Supplier 
CD31 rat 1/50 n.aa 550274 Becton Dickinson 
E-CAD rat 1/200 n.a U3254 Sigma 
GCM2 rabbit 1/200 1/500 ab64723 Abcam 
GFP chick 1/1000 1/1000 ab13970 Abcam 
HLXB9 rabbit 1/1000b 1/1500 ab26128 abcam 
INS guinea pig 1/200 n.a A0564 Dako 
NKX2.1 mouse 1/200 1/500 PA0100 Biopat Im. 
PITX2 rabbit 1/500 1/1000 PA1020 Capra Science 
PROX1 goat n.a 1/500 homemadec 
PROX1 rabbit 1/100 n.a AF2727 R&D Systems 
pSMAD1/5/8 rabbit 1/200 n.a 9511 Cell Signaling 
SOX2 rabbit 1/200 n.a AB5603 Chemicon 
 
 
Table 2.4. Secondary Antibodies 
Against Origin Conjugated Sections and wholemount Supplier 
chick donkey Al488 1/800 Thermo Fisher Sci. 
goat donkey Al568 1/1000 Thermo Fisher Sci. 
goat donkey Al488 1/1000 Thermo Fisher Sci. 
guinea pig goat Al568 1/800 Thermo Fisher Sci. 
mouse donkey Al568 1/1000 Jackson IR 
mouse donkey Al488 1/1000 Thermo Fisher Sci. 
rabbit donkey HRPd 1/100 Jackson IR 
rabbit donkey Al488 1/200 Jackson IR 
rat donkey Al647 1/500 Jackson IR 
 
                                                
 
a n.a. non applicable 
b Antigen recovery was performed in this case 
c Gift from Tatiana Petrova 
d Tyramide Signal Amplification kit used for detection 
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Results and discussion 
 
 3.1. Characterization of the new Sox17CreERT2 line 
 A Sox17CreERT2 mouse was previously generated in our lab by Marine Rentler-
Courdier. In order to generate the Sox17CreERT2 ES cell line, the coding sequence of a 
CreERT2 fusion protein was targeted after the second exon of Sox17 disrupting the 
gene. From this ES cell line, a mouse line was generated (unpublished data). The main 
difference between this mouse strain and the one reported by Engert (2013) is that the 
Sox17 gene is disrupted in the mutant allele.  
 Sox17 is expressed transiently in different tissues. Recombination will therefore 
occur in the cells that are expressing Sox17 if the activated form of tamoxifen is 
present as it is required for the translocation of the CreERT2 to the nucleus. In order to 
evaluate tamoxifen induced cell recombination in this new CreERT2 line, heterozygous 
mice were crossed with the Rosa26YFP/YFP (R26) Cre reporter mice51. In their progeny, 
yellow fluorescent protein (YFP) is expressed after Cre-mediated excision of the loxP-
flanked stop cassette from the ubiquitously expressed Rosa26 locus, allowing the 
detection of the recombined cells. Different injection time points with variable doses 
were investigated in order to reach the maximum recombination efficiency in the DE 
with little effect on the vasculature and the yolk sac.  
 We initially chose to activate Cre by tamoxifen injection at E7.5 (Figure 3.1), 
when expression of Sox17 is mostly restricted to the DE42,53. In order to get a 
homogenous recombination rate among litters, the dose of injected tamoxifen is 
function of the weight of the pregnant female and expressed as the amount of 
tamoxifen per 10g of mice (mg/10g).  
Another critical point was the age of the tamoxifen solution. Indeed, oil solubilized 
tamoxifen is unstable. However, its degradation also coincides with a reduced toxicity. 
Indeed, it was possible to harvest E12.5 embryos which received 0.7mg/10g of 
tamoxifen at E7.5 with a tamoxifen solution was older than 3 months (n=1). With this 
setting, most of the cells in the gut endoderm as well as in the endoderm derived 
organs expressed YFP (Figure 3.1 - A-C). Concomitantly, no recombined cells were 
found in the yolk sac epithelium (Figure 3.1 - D) and only few in the vasculature (Figure 
3.1 - E - white arrow), indicating that at the time of injection Sox17 expression was 
almost limited to the DE, with only few cells of mesodermal origin being Sox17+.. 
 On the contrary, when attempting to repeat the experiment, it was observed that 
injection of the same dose of freshly prepared tamoxifen was lethal (n>5). Since it 
FCUP 
Role of the BMP Pathway in Definitive Endoderm Patterning 
26 
 
 
 
 
 
cannot be excluded that the outcome on the recombination will be more variable due to 
the partial tamoxifen degradation, further injections were performed with fresh 
tamoxifen, solubilized less than three days-old prior to injection.  Nevertheless, the 
previous experiment showed that the time window of injection targeted mostly DE cells. 
 Since tamoxifen injection of 0.7mg/10g was lethal for the litter, most probably 
due to cardiac developmental defects, lower doses of tamoxifen were used. A 
tamoxifen injection of 0.6mg/10g was found to be the highest dose administered at 
E7.5 that does not cause high rates of developmental delay and malformation followed 
by abortion. At E9.5  the number of recombined cells was variable across different 
litters, and never higher than 30% when 0.6mg/10g or 0.5mg/10 were injected (n=5 
combining 0.5mg/10g and 0.6mg/10g) (Figure 3.2). The recombination variability may 
be caused by the lower dose of tamoxifen as a critical amount is necessary for Cre 
Figure 3.1. Recombination rates in E12.5 embryos after administration of out of date tamoxifen at E7.5. (A-D) 
Immunofluorescence for E-Cadherin and GFP on sections of Sox17CreERT2/+ RosaYFP/+ E12.5 embryos shows the 
recombination when old tamoxifen is injected at E7.5. Around 70 to 90% of the gut endoderm highlighted by E 
Cadherin (red) were recombined and expressed YFP detected by the GFP antibody as exemplified in the trachea and 
esophagus (A), the pancreas (B) and the midgut (C). Only few GFP positive cells were observed in the yolk sac 
epithelium (red) (D). (E) Immunofluorescence for CD31 and GFP on sections of Sox17CreERT2/+ RosaYFP/+ E12.5 
embryos shows rare event of recombination in the endothelial cells expressing CD31 (red) when old tamoxifen is 
injected at E7.5. Nuclei are counterstained with DAPI (blue). Abbreviations: es - esophagus; tr - trachea; vp - ventral 
pancreas; mg - midgut. Scale bar - 100 µm. 
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activation and by the dynamic expression of Sox17. But also, considering the rapid shift 
in Sox17 expression, it is likely that even small discrepancies in the time of tamoxifen 
injection will result in the recombination of different groups of cells. Sox17 expression is 
first found in the prospective foregut (E7.0) and gradually shifted until it is only found in  
the prospective hindgut (E9.0)42. In line with the dynamic expression pattern, it was 
observed that often more cells were recombined in the posterior region of the gut than 
in the foregut (Figure 3.2 A-C), which indicates that the DE cells of the foregut were no 
longer Sox17+ at the time of Cre activation. 
 According to the previous experiment, an earlier injection than E7.5 would be 
needed in order to induce recombination in the prospective foregut cells. Preliminary 
experiments in the lab have shown that injection of 0.7mg/10g at E6.5 leads to high 
recombination rate (around 90%) in the whole gut at E9.5 but results in embryonic 
lethality since no embryo survived after E10.5 (unpublished data). It is noteworthy that 
the tamoxifen solution used for this experiment was not fresh. Therefore, a strategy 
Figure 3.2. Recombination rates in E9.5 embryos after administration of tamoxifen at E7.5. (A-C) 
Immunofluorescence for E-Cadherin and GFP on sections of Sox17CreERT2/+ RosaYFP/+ E9.5 embryos shows the 
recombination when tamoxifen is injected at E7.5 with a dose of 0,5 mg/10g or (D) a dose of 0,6 mg/10g. Few cells of 
the gut endoderm highlighted by E Cadherin (red) were recombined and expressed YFP detected by the GFP 
antibody. Often, more cells were recombined in the posterior region gut as exemplified in the hindgut compared to the 
foregut (A and C). Nuclei are counterstained with DAPI (blue). Abbreviations: es - esophagus; tr - trachea; vp - ventral 
pancreas; mg - midgut. Scale bars - 100 µm. 
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combining lower doses of tamoxifen (0.4mg/10g) injected at two different time points 
was undertaken in order to improve the recombination in Sox17+ DE cells and the 
viability of the embryos. Using this approach, we observed that between 70 to 90% of 
the cells in the gut endoderm were recombined both at E9.5 (n=2) and E12.5 (n=4). For 
example, most of the cells in the liver primordium were recombined at E9.5 (Figure 3.3 
- B) and high recombination rates in the pancreas were observed at E12.5 (Figure 3.3 - 
E). The recombination in the vasculature might be caused by the presence of 
tamoxifen metabolites long after injection. The precise length of time that tamoxifen 
continues to induce recombination is highly variable depending on the dose and mode 
of administration54,55. Nevertheless, the low rates of recombination observed in the 
vasculature (~1%) in this experiment would be unlikely to interfere when analysing DE  
 
 
Figure 3.3. Recombination rates in E9.5 and E12.5 embryos after administration of tamoxifen twice, at E6.5 
and E7.5. (A-C) Immunofluorescence for E-Cadherin and GFP on sections of Sox17CreERT2/+ RosaYFP/+ E9.5 embryos 
shows the recombination when tamoxifen is injected at E6.5 and E7.5 with a dose of 0,4mg/10g/day. Around 70 to 
90% of the gut endoderm cells highlighted by E Cadherin (red) were recombined and expressed YFP detected by 
the GFP antibody as exemplified in the foregut (A), the liver primordium (B) and the hindgut (C). (D-F) 
Immunofluorescence for E-Cadherin and GFP on sections of Sox17CreERT2/+ RosaYFP/+ E12.5 embryos shows the 
recombination when tamoxifen is injected at E6.5 and E7.5 with a dose of 0,4mg/10g/day. Around 70 to 90% of the 
gut endoderm highlighted by E Cadherin (red) were recombined and expressed YFP detected by the GFP antibody 
as exemplified in the esophagus and main bronchi (D), dorsal pancreas (E) and the midgut (F). Nuclei are 
counterstained with DAPI (blue). Abbreviations: br - bronchi; es - esophagus; dp - dorsal pancreas; mg - midgut. 
Scale bars - 100 µm.  
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lineage-restricted conditional mutants. This double injection strategy was found to be 
the most effective and reliable way to induce DE specific Cre activity with this new 
Sox17CreERT2 line.  
 After E9.0, Sox17 expression is found on a subset of endothelial cells of the 
blood vessels, including the dorsal aorta45. When Sox17 is no longer expressed in the 
DE, it is re-expressed in the ventrolateral region of the most posterior foregut, where 
the bile duct and gall bladder originate46. In order to verify the ability of the Sox17CreERT2 
line to recombine cells in these tissues, 0.7mg/10g of tamoxifen were administered at 
E10.5 and the embryos harvested at E14.5 (n=2), when the organs and vasculature 
are mainly formed. We observed that many endothelial cells in the vasculature were 
recombined, e.g in the dorsal aorta (Figure 3.4 - A-C). Furthermore, recombined cells 
were found in the bile duct, in accordance with Sox17 expression (Figure 3.4 - D-F). 
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It has been shown that Sox17 is still expressed at E9.0 in the ventral 
pancreas50. However, none of the pancreatic cells expressed YFP indicating that by 
E10.5, Sox17 is no longer expressed in this organ (Figure 3.5). 
 After birth, SOX17 is essential for the regulation of insulin secretion in beta-
cells. Mice lacking Sox17 during pancreas organogenesis are more susceptible to 
develop diabetes56. Although no mature beta cells are present at E10.557, there are 
some cells co-expressing insulin and glucagon. They were not GFP positive at E14.5 
indicating that neither the progenitors of beta cells nor the glucagon/insulin double-
positive cells express Sox17 at E10.5 (Figure3.5). 
 
Figure 3.4. Recombination rates in E14.5 embryos after administration of tamoxifen at E10.5. (A-C) 
Immunofluorescence for GFP (green, single channel image (A)) and CD31 (gray, single channel image (B)) on 
sections of Sox17CreERT2/+ RosaYFP/+ E14.5 embryos shows the recombination when tamoxifen is injected at 
E10.5. Very high numbers of recombined cells were observed in the vasculature. (D-F) Immunofluorescence for 
GFP (green, single channel image (D)) and E-Cadherin (gray, single channel image (E)) on sections of 
Sox17CreERT2/+ RosaYFP/+ E14.5 embryos shows the recombination when tamoxifen is injected at E10.5. Very high 
numbers of recombined cells were observed in the bile duct.. Nuclei are counterstained with DAPI (blue). 
Abbreviations: da - dorsal aorta; bd - dile duct. Scale bars - 100 µm. 
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 Overall, these experiments confirm that the new Sox17CreERT2 mouse line is 
inducible upon tamoxifen injection and expresses Cre in the expected cell types (Table 
3.1). Furthermore, we showed that recombination in the Rosa26 locus is very efficient 
in the endoderm when tamoxifen is administered at E6.5 and E7.5,  as in these 
conditions most cells in the endoderm expressed YFP. Recombination can also be 
induced in precursors of the vascular endothelial lineage as well as in the bile duct. The 
spatiotemporal induction of Cre in this line allows genetic lineage tracing of distinct 
Sox17+ populations, as well as tissue-specific gene edition.  
 As stated previously, the Sox17 gene is disrupted in this Sox17CreERT2 line. It 
has been shown that this haploinsufficiency may be an issue depending of the genetic 
background of the animals. In a C57BL/6 background, 90% of the Sox17+/- mice suffer 
perinatal lethality due to aberrant development of the liver, gallbladder and bile duct 
network. The same study reported that in the ICR background a mild phenotype of 
gallblader hypoplasia is observed  only in adults58. This new Sox17CreERT2 line is bred 
on an ICR background.  We did not observe obvious defects; the mice could reach 
adulthood and were fertile. However, when performing additional mutations this must 
be taken into account, as it may have an unpredictable effect. 
 On the other hand, this same characteristic raises the possibility to perform 
interesting experiments regarding the fate of Sox17 deficient cells, which has been only 
briefly explored to date59. 
 
Figure 3.4. Recombinantion rates in E14.5 pancreas after administration of 
tamoxifen at E10.5. (A-E) Immunofluorescence for GFP (green, single channel 
image (A)), insulin (red, single channel image (B)) and E-Cadherin (gray, single 
channel image (C)) on sections of Sox17CreERT2/+ RosaYFP/+ E14.5 embryos shows the 
recombination when tamoxifen is injected at E10.5.Insulin secreting cells (yellow 
arrows , magnification (E)) in the E14.5 pancreas were not recombined. Pannel (E) 
represents a magnification of the dashed area in (D). Nuclei are counterstained with 
DAPI (blue). Abbreviations: dp - dorsal pancreas. Scale bars - 100 µm.  
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Table 3.1. Summary of characterization of the Sox17CreERT2 line 
Time of Injection 
Cells recombined 
VE DE Vasculature 
 
E7.5 minimal 
variable, usually higher on 
posterior minimal 
E6.5-7.5 minimal yes (80-90%) minimal 
E10.5 none bile duct yes (~80%) 
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 3.2. Expression of molecular markers in the gut 
 To determine the effect of the absence of BMP signalling on the dorso-ventral 
patterning of the endoderm, the organ domain will be assessed at E10.5 using 
molecular markers. At this time point, morphological features are present only for some 
organs e.g. lungs, the pancreas and the liver. A series of organ-specific markers were 
selected based on their early expression in the different endoderm-derived organ 
domains (Table 3.1). The immunohistofluorescence protocol for every marker was 
optimized on E10.5 wild-type (WT) embryos both for whole-mount staining and on 
sections. The subsequent figures show the results of the optimization on sections. 
  
Table 3.2. Molecular markers expressed in the primitive gut and assessed 
in this study 
Molecular maker Region Onset of expression 
NKX2.1 thyroid, lungs, trachea 8.5 60 
SOX2 esophagus 9.561 
FOXN1 thymus 1162 
GCM2 parathyroid 9.562 
PROX1 liver 8.563 
HLXB9 dorsal gut, pancreas 8.064 
PITX2 caecum 1165 
 
 
 3.2.1. Nkx2.1 and Sox2 
 Nkx2.1 and Sox2 encode transcription factors that inhibit each other's 
expression. Therefore, their expression is mutually exclusive in different domains of the 
foregut. They are necessary for the proper formation of the trachea and the esophagus, 
respectively37,61. NKX2.1 is expressed in the ventral foregut endoderm as well as in the 
lungs and the thyroid, as was observed in E10.5 WT embryos (Figure 3.6). 
Wholemount stainings of the thyroid and lungs were also successful (Supplementary 
video 1 and 2). Complementary to the ventral expression of NKX2.1, high levels of 
SOX2 marked the dorsal foregut endoderm (Figure 3.7). SOX2 expression was also 
detected at lower levels in the main bronchi (Figure 3.7 - B, C). Indeed, this 
transcription factor has been shown to inhibit lung branching and its overexpression in 
the respiratory epithelium causes a severe reduction in the number of airways66. 
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 3.2.2. Gcm2 and Foxn1 
 The thymus and parathyroid glands originate from the same endodermal 
primordium and develop bilaterally, in the third branchial pouch. In the adult, the 
thymus is situated above the heart and is responsible for T cell production, whereas the 
parathyroids are found near the thyroid and regulate calcium homeostasis. By E9.5 the 
thymus and parathyroid start to be specified, but they cannot be morphologically 
Figure 3.7. SOX2 in WT E10.5 embryos. (A-C) Immunofluorescence for SOX2 (green) was performed on WT 
E10.5 embryonic sections. SOX2 is found in the esophagus. Trachea can be morphologically distinguished (white 
lines) (A) as well as the main bronchi (B, C). SOX2 is found at lower levels in the main bronchi (C). Nuclei are 
counterstained with DAPI (blue). Abbreviations: es - esophagus; tr - trachea; br - bronchi. Dorsal is towards the top 
and ventral towards the bottom. Scale bar - 100 µm. 
 
Figure 3.6. NKX2.1 in WT E10.5 embryos. (A-D) Immunofluorescence for NKX2.1 (green) was performed on WT 
E10.5 embryonic sections. NKX2.1 is found in the thyroid (A) in the trachea (B,C) and in the main bronchi (D). The 
esophagus can be morphologically distinguished and do not expressed NKX2.1 (B, C, D - yellow lines). Nuclei are 
counterstained with DAPI (blue). Abbreviations: th - thyroid; es - esophagus; tr - trachea; br - bronchi. Dorsal is 
towards the top and ventral towards the bottom. Scale bar - 100 µm. 
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distinguished at this point. GCM2 marks the dorsal region in the common primordium 
which later becomes the parathyroid (Figure 3.8), while Foxn1 is expressed in the 
ventral domain that originates the thymus. However its expression only starts at E11 
making it less suitable for this study62. Wholemount stainings of the parathyroid was 
also successful (Supplementary video 3). 
 
 
 3.2.3. Prox1 
 PROX1 is found in the liver, in both pancreatic buds and in the bile duct at 
E10.5 (Figure 3.9). Wholemount stainings of the liver, pancreas and bile duct with 
Prox1 were also successful (Supplementary video 4).  Expression in the liver domain 
starts at E8.5 and is first observed in the budding dorsal pancreas at E9.563.  
 
 
Figure 3.7. PROX1 in WT E10.5 embryos. (A, B) Immunofluorescence for PROX1 (green) was performed on WT 
E10.5 embryonic sections. PROX1 is found in the liver (A, B), the bile duct (A) and in the pancreatic buds, e.g. 
dorsal pancreatic bud (B). Nuclei are counterstained with DAPI (blue). Abbreviations: bd - bile duct; dp - dorsal 
pancreas; li - liver. Scale bar - 100 µm. 
 
Figure 3.7. GCM2 in WT E10.5 embryos. Immunofluorescence for GCM2 (green) 
was performed on WT E10.5 embryonic sections. GCM2 is found in a small domain 
located dorsally on the third branchial pouch, where the parathyroid will develop. 
Nuclei are counterstained with DAPI (blue). Abbreviations: pt - parathyroid. Scale bar - 
100 µm. 
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 3.2.4. Hlxb9 
 HLXB9 is found all along the dorsal wall of the gut epithelium as well as in the 
dorsal pancreas (Figure 3.10). Hlxb9 is also expressed transiently in the ventral 
pancreas. After E10.5, only the differentiating beta-cells and the beta cells expressed 
Hlxb9 in the pancreas64.  Wholemount stainings of with hlxb9 were also successful 
(Supplementary video 5). 
 
 
 
 3.2.5. Pitx2 
 Pitx2 is expressed in the epithelium and the mesenchyme of the caecum 
primordium from E11.0. It is required for the formation of the caecum67. Commercial 
antibodies against PITX2 were tested on E10.5 embryos. However, the different tests 
did not give any conclusive results. This may result from PITX2 not yet being 
expressed at this stage or defective antibodies, hypotheses that were not yet tested. 
 
 3.2.6. Effectors downstream of BMP: pSMAD1/5/8 
 In order to monitor BMP pathway activity, we evaluated the presence of a 
downstream effector, the phosphorylated form of SMAD1/5/8 (pSMAD1/5/8. 
Figure 3.10. HLXB9 in WT E10.5 
embryos. (A, B) Immunofluorescence for 
HLXB9 (green) was performed on WT 
E10.5 embryonic sections. HLXB9 is found 
dorsally all along the gut endoderm. (A, B, 
C). HLXB9 was also found in the dorsal 
pancreatic bud (D). Nuclei are 
counterstained with DAPI (blue). Dorsal is 
towards the top and ventral towards the 
bottom. Abbreviations: bd - bile duct; dp - 
dorsal pancreas; li - liver. Scale bars - 100 
µm. 
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pSMAD1/5/8 immunoreactivity should be absent when BMP signalling is inactive. In 
wild-type E9.5 and E10.5 embryos, pSMAD1/5/8 was observed ventrally in the gut 
endoderm and in the surrounding mesoderm (Figure 3.11 - A, B). To assess the 
specificity of the antibody, a phosphatase treatment was performed; in this case no 
signal was detected in the ventral part of the gut and the surrounding ventral 
mesoderm (Figure 3.11 - C). 
 
3.2.7. Sequential immunofluorescence 
 Multiple antibodies presented in this section are generated in the same species 
(See Table 2.1 in Materials and Methods). Critically, both HLXB9 and pSMAD1/5/8 
antibodies were raised in rabbit. To circumvent this issue, we developed a strategy of 
sequential immunofluorescence. With this method, two rounds of immunofluorescence 
staining using antibodies raised in the same species are performed separated by a 
Figure 3.11. pSMAD1/5/8 in WT embryos and phosphatase treatment. (A, B) Immunofluorescence for 
pSMAD1/5/8 (green, single channel image (A, B, C)) was performed on WT E9.5 (A) and E10.5 (B) embryonic 
sections. pSMAD1/5/8 staining is found in the ventral region of the gut and the surrounding mesenchyme. (C) 
Phosphatase treatment followed by immunnofluorescence on sections for pSMAD1/5/8 (green) on E10.5 WT 
embryos. After treatment with phosphatase, no pSMAD1/5/8 staining is observed, which assures the antibody 
specificity. Nuclei are counterstained with DAPI (blue). Unspecific signals coming from the blood cells are evident in 
C. The gut epithelium is outlined. Dorsal is towards the top and ventral towards the bottom. Scale bar - 100 µm.  
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stripping procedure which removes the primary and secondary antibodies of the first 
staining. If a fluorescent precipitate, such as tyramide, is used to detect the first 
immunofluorescence, it is possible to visualize both signals at the same time as the 
stripping does not remove the precipitate Therefore, in the presented example, it was 
possible to image together HLXB9 and pSMAD1/5/8 signals (Figure 3.12).  
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Figure 3.12. pSMAD1/5/8 in a E10.5 embryo after stripping primary antibodies. (C, F, I) Immunofluorescence 
was performed for HLXB9 (red, single channel image (A, D, G)) on E10.5 embryonic sections using a tyramide dye. 
This was followed by antibody stripping and subsequent immunofluorescence for pSMAD1/5/8 (green, single 
channel image (B, E, H)). HlLXB9 is found in the esophagus (red), whereas pSMAD175/8 is found in the ventral gut 
region (green) (C, F,I). Nuclei are counterstained with DAPI (blue). Dorsal is towards the top and ventral towards the 
bottom. Abbreviations: fg - foregut; es - esophagus; tr - trachea. Scale bar - 100 µm.  
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3.3. Inactivation of the BMP pathway  
 Inactivation of the BMP pathway in the gut endoderm was achieved by 
conditionally inactivating Alk3 using the previously characterized Sox17CreERT2 mouse 
line, in a null background for Alk6. The pathway was thereby permanently inactivated in 
the progeny of the cells that expressed Sox17+ at the time of tamoxifen injection in the 
Sox17creERT2/+; Alk3fl/fl; Alk6–/–embryos (hereafter called dKO). As discussed previously, 
injection of tamoxifen at E6.5 and E 7.5 in the presented CreERT2 line causes 
widespread recombination of Sox17+ DE progenitor cells.  
 The inactivation of the pathway was achieved via the receptors and not through 
the ligands. Indeed, BMPs are present in both the endoderm and the surrounding 
mesenchyme. Their deletions may result in deleterious effects in the mesenchyme, 
impairing further analysis. Moreover, the receptors are less redundant than the ligands 
and deletion of both main receptors ALK3 and ALK6 are expected to avoid 
compensatory mechanisms due to their redundancy. 
 
 3.3.1. Inactivation of both receptors is lethal before E10.5 
 Unexpectedly, double knock-out (dKO) embryos did not survive until E10.5. The 
effect was not due to tamoxifen toxicity in this background since wild-type and 
heterozygote littermates were recovered in the expected ratios (Figure 3.13). A single 
dKO embryo was found, but wholemount analysis suggests that the inactivation of the 
pathway was likely not achieved in this litter, as none of the littermates presented 
abnormalities (see subsequent sections and data not shown). Early embryonic lethality 
is often associated with gastrulation defects. However, the pathway inactivation was 
induced by injecting tamoxifen after gastrulation has occurred excluding this 
hypothesis. Due to the time at which BMP inactivation was performed, we suspect that 
the absence of BMP signalling in the DE at this stage interferes with gut tube closure 
and embryonic turning, precluding further development. Interestingly, mice with the 
Sox17CreERT2/+; Alk3fl/fl; Alk6–/+ genotype (hereafter termed Hz) survived until E10.5, 
indicating that the presence of a single allele of Alk6 is sufficient to prevent the lethal 
phenotype observed in the dKO. It is noteworthy that ALK6 is first expressed in the AIP 
at E7.522 suggesting that the absence of BMP signalling in the AIP at around E7.5 
causes lethality. The AIP is the place where ventral gut closure begins, indicating that 
BMP signalling in the DE may be required for ventral closure of the gut. It is supported 
by the effect of the deletion of Furin, an enzyme responsible for activation of BMP418. 
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Furin knock-out embryos are unable to undergo ventral closure and axial turning68. 
However, it cannot be excluded that Alk6 compensates the absence of Alk3 in other 
parts of the endoderm where ALK6 is normally not required. To verify this hypothesis, 
the phenotype of dKO embryos should be analysed at earlier stages, such as E8.5. It 
would also be important to analyse the expression of ALK6 in the Hz embryos before 
E10.5 to evaluate putative compensatory mechanisms. 
 We proceeded to analyse the phenotype of Hz mutants by comparing it to wild-
type littermates, mainly through wholemount immunofluorescence. 
 
 
  
 3.3.2. Hz embryos have several organ development defects 
 Even though Hz embryos survived until E10.5, they harboured several 
developmental defects, indicating that lowering BMP activity in the gut is sufficient to 
disrupt appropriate endoderm-derived organogenesis (Figure 3.14). Moreover, we also 
noticed that the epithelium of the gut of the Hz mutant looked globally thinner and less 
compact (Figure 3.14, 3.15, 3.16). It may be due to a proliferation defect occurring in 
the primitive gut endoderm of the Hz mutant. Accordingly, the absence of BMP4 in the 
anterior foregut causes a proliferation defect without an increase of cell death36. The 
growth impairment may also be more global as the Hz embryos were smaller than their 
WT littermates. Thus, it will be important to assess the cell survival and proliferation at 
E10.5 and earlier to understand this defect. 
 All Hz embryos analysed by wholemount immunofluorescence (n=3) lacked 
expression of NKX2.1 (Figure 3.14). While the thyroid, the trachea and lungs were 
normal in wild-type embryos (Figure3.14 - A), they were not visible in their Hz 
littermates (Figure3.14 - B). Even though the presence of the thyroid domain was not 
Figure 3.13. Percentages 
of genotypes obtained 
overall (A) compared to 
the theoretical percenta- 
ges (B) at E10.5. The 
proportions of genotypes 
obtained were similar to 
those expected, with the 
exception of the dKO, 
which was lethal.   
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investigated with other markers or at a later time point when the primordium is formed, 
the data suggests that it will not form, since Nkx2.1 is critical for its development69. In 
order to closely observe the structure of the foregut in the Hz mutant, one embryo 
(n=1) was sectioned after wholemount staining. No lungs or trachea were observed 
(Figure 3.16 - D). The absence of trachea stained by NKX2.1 in the mutant agrees with 
the requirement of BMP4 for its development36. Previously, disruption of BMP signalling 
in the foregut after specification had been shown to cause defects in lung development. 
The lungs formed but were smaller and less branched37. However, the inactivation of 
BMP signalling was performed after specification contrary to our study, in which no 
lungs are observed suggesting that the BMP pathway is also necessary for lung 
specification. However, it will be important to analyse the mutant at earlier stages to 
confirm that BMP signalling is required for lung specification in addition to the 
maintenance of its identity. 
 
Figure 3.14. Three-dimensional projection of WT and Hz littermates, at E10.5. (A, B) Wholemount 
immunofluorescence for HLXB9 (green), NKX2.1 (red) and PROX1 (white) in E10.5 WT /A) and Hz (B) embryos 
after injection of tamoxifen at E6.5 and E7.5. In the WT, NKX2.1 is present in the thyroid and lungs; HLXB9 is 
present in the dorsal region along the whole gut tube as well as in both pancreatic buds; PROX1 is present in the 
liver, the gallbladder and in both pancreatic buds (A). In the Hz mutant no NKX2.1 was found; HLXB9 is still present 
dorsally in the gut tube, but the epithelium seems thinner and deformed; PROX1 is expressed only on the right side 
of the embryo (B - L|R panel); the ventral pancreas and gallbladder are not evident. PROX1 and HLXB9 are found 
overlapping dorsally (arrowhead) (B). The strong red signal seen in A is a result of antibodies eing trapped in the 
lumen of the gut tube.  Abbreviations: dp - dorsal pancreas; gn - galbladder; li - liver; lu - lungs; th - thyroid; vp - 
ventral pancreas; H - heart; L - left; R - right.  
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At E10.5, PROX1 was expressed in the liver, in both pancreatic buds and in the 
gallbladder in WT embryos. Moreover, each structure was distinguishable 
morphologically and the liver already had its characteristic sinusoidal shape (Figure 
3.14 A). In the Hz mutant, none of the aforementioned structures was distinguishable 
(Figure 3.14 B). The position and the arrangement of the cells suggested that the 
majority of PROX1+ cells were hepatocytes, while the rest might have a dorsal 
pancreatic identity. Nevertheless, more markers should be used in order to assess the 
identity of the PROX1+ cells.  
Figure 3.15. . Comparison of foregut in the WT and Hz littermates at E10.5. (D, H) Immunofluorescence for HLXB9 
(green, single channel (A, E)), Prox1 (white, single channel (B, F)) and NKX2.1 (red, single channel (C, G)) on E10.5 
embryonic sections, after wholemount immunofluorescence. HLXB9 is found in the dorsal region of the gut in both WT 
and Hz littermates. Expression of HLXB99 is also observable in the neural tube and the notochord (A, E). NKX2.1 is 
found in the ventral region of the gut in the WT (G) but not in the Hz littermate (C). The overexposed signal in the gut 
lumen in H is an artefact of wholemount immunofluorescence. Nuclei are counterstained with DAPI (blue). The gut 
epithelium is outlined. Dorsal is towards the top and ventral towards the bottom. Abbreviations: fg - foregut; nc - 
notochord; nt - neural tube. Scale bars - 100 µm 
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PROX1+ domain was also drastically reduced. Its total volume was estimated in 
the Hz mutants and in their WT littermates (n=3) using the Imaris 8.1 software (Figure 
3.17). However, slight differences of the embryonic stage at the time of collection 
cause a high variation in the organ domain size, as organogenesis is fast evolving at 
these stages. Combined with the small number of cells (Figure 3.14 ) forming PROX1+ 
domain, it could explain why its  
volume might be 6 times higher in the largest compared to the smallest WT of different 
litters. For this reason the volume of PROX1 in the Hz mutant was normalized to the 
volume of its WT littermate (Figure 3.18). This analysis revealed that the total PROX1 
expression domain is significantly reduced in the Hz mutant. 
 
Figure 3.16. Comparison of lung and liver in the WT and Hz littermates at E10.5. (D, H) Immunofluorescence for 
HLXB9 (green, single channel (A, E)), PROX1 (white, single channel (B, F)) and NKX2.1 (red, single channel (C, G)) on 
E10.5 embryonic sections, after wholemount immunofluorescence. HLXB9 is found in the dorsal region of the gut in both 
WT an Hz littermates (A, E). NKX2.1 is found in the ventral region of the gut where the lungs are budding in the WT (G) 
but not in the Hz littermate (C). PROX1 is expressed both in the WT (F) and in the Hz littermates (B). In the WT different 
organs can be distinguished by morphological aspects (H - liver/gallbladder). In the Hz however the PROX1 domain is 
reduced and no evident morphological structures were observed. The overexposed signal in the gut lumen is an artefact 
of wholemount immunoflourescence. Nuclei are counterstained with DAPI (blue). The gut epithelium is outlined. Dorsal 
is towards the top and ventral towards the bottom. Abbreviations: gb - gallbladder; li - liver, lu - lungs. Scale bar - 100 µm 
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Figure 3.18. Total Prox1 volumes in the Hz 
embryos (% of WT littermate). The volumes 
obtained for the Hz mutants through surface 
rendering in the Imaris software were plotted 
normalized to the WT volumes (n=3). PROX1 
domains are significantly smaller in the Hz mutants 
than in the WT littermates. Orange - Litter 1; Green 
- Litter 2; Blue - Litter 3. *One sample t test p=0,01  
Figure 3.17. Surface rendering of prox1 
expression domain. The three dimensional 
PROX1 domains were isolated from the 
remaining three dimensional image (white, A, B). 
Using the Imaris 8.1 software surfaces were 
rendered based on PROX1 signal (green, C, D). 
The same settings were replicated for each 
surface simulation. 
 
 
Before ventral closure, the liver starts developing bilaterally in the lateral 
endoderm. Both primordia meet and form a single organ when the lateral endoderm 
migrates ventrally70. Interestingly, the putative liver observed in the Hz mutant was 
located on the right side of the embryo (Figure 3.14 B), suggesting that the 
specification process of the right and left liver primordia are differently affected by BMP 
signalling. Furthermore, the pre-cardiac mesoderm which is necessary for the 
specification of the hepatogenic endoderm also receives reciprocal signals from this 
tissue to further develop71. In the Hz mutant, the heart also appears smaller when 
visualized with PROX1 staining (Figure 3.14 B). It might be a consequence of lack of 
reciprocal signalling between the liver and the pre-cardiac mesoderm.   
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 Remarkably, no ventral pancreatic bud was formed in any of the Hz embryos 
while the outcome of the alteration of BMP signalling on the dorsal pancreatic bud was 
variable. In one instance, the dorsal pancreas seemed completely absent based on 
PROX1 and HXLB9 staining. In another litter, there was no apparent budding but 
PROX1 and HLXB9 expression overlapped dorsally, in the prospective region of the 
dorsal pancreatic bud (Figure 3.14 B). Finally, in the third litter, a bud was observed, 
although it was underdeveloped compared to its WT counterpart (Figure 3.19 C, F). 
The variable dorsal pancreatic phenotype may be linked to a slight difference in the 
developmental stage of the embryos or to differences in recombination rates between 
litters. These data indicate that BMP signalling is probably required for the specification 
of the ventral pancreatic bud while the effect of BMP signalling on dorsal pancreatic 
bud is less clear but suggest it is required for pancreatic growth, as previously 
suggested in chick72. 
Figure 3.19. Comparison of dorsal pancreas in the WT and Hz littermates at E10.5. (C, F) Immunofluorescence 
for HLXB9 (green, single channel (A, D)) and PROX1 (white, single channel (B, E)) on E10.5 embryonic sections, 
after wholemount immunofluorescence. Overlapping domains of HLXB99 and PROX1 as well as the morphology, 
indicate that the dorsal pancreas is present both in the WT (F) and the Hz mutant (C). Nuclei are counterstained 
with DAPI (blue). Abbreviations: dp - dorsal pancreas. Scale bar - 100 µm 
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 The global dorsal molecular marker HLXB9 was expressed in the dorsal 
endoderm of both WT and Hz embryos. Although the size of the domain has not been 
quantified, it implies that the dorsal identity of the primitive gut tube remains unaffected.  
 In summary, the resulting phenotype shows that the inactivation of BMP 
signalling through the ALK3 receptor and partially through the ALK6 receptor disturbs 
the ventral patterning of the anterior foregut as well as the formation of several organs, 
including the dorsal pancreas. Globally, the gut epithelium of Hz mutants appears to be 
thinner and less shapely while the surrounding mesoderm did not seem affected by the 
alteration of BMP signalling, indicating that conditional deletion of Alk3 in the endoderm 
was successful. The heart developmental defect is likely associated to the lack of 
reciprocal signalling from the liver endoderm, since this organ is significantly reduced.  
   
 In this study we provide evidence that the disruption of BMP signalling in the 
endoderm after onset of gastrulation causes embryonic dead before E10.5. Uncovering 
the developmental defects that cause death in these embryos will provide further 
information on the role of BMP signalling in the endoderm during these stages. 
 Furthermore, the preliminary results on characterization of the Hz phenotype 
reveal that disturbance of BMP signalling in the endoderm results in global defects in 
the endoderm. To achieve a deeper understanding of the phenotype of the Hz mutants, 
several further experiments could be conceived. The extent of BMP signalling 
inactivation in the Hz mutant should be assessed by evaluating pSMAD1/5/8 levels in 
the gut, as described in section 3.2.6. This experiment would reveal to which extent 
endodermal cells have undergone recombination and the level of BMP signalling in 
other cells. Alternatively, a recombination reporter could be included in the breeding 
scheme. The analysis of other endoderm-derived organs is also required. Indeed the 
global ventralizing activity of BMP is unclear since the dorsal pancreatic bud is either 
hypoplastic or absent and HLXB9 domain does not appear to be extended ventrally. 
Therefore, in order to assess our hypothesis, it will be important to evaluate the 
presence of the other dorsal organ, the parathyroid, by analysing the expression of 
GCM2. In addition, a ventral posterior organ, the caecum, could be assessed by 
expression of Pitx2 in the Hz embryo, possibly by in situ hybridization. It will also be 
interesting to examine pancreatic specific markers, such as PTF1A or PDX1, in order 
to differentiate the liver, the pancreas and the gallbladder. Additional global markers 
like SOX2 (dorsal foregut) and Islet1 (global ventral in chick, Palle Serup unpublished 
data) might offer further insight into which targets are affected by BMP signalling. As 
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our analyses cannot rule out a defect in the maintenance of the identity of the 
endoderm-derived organs, the Hz mutants should also be studied at earlier stages. A 
part of the observed phenotype might be associated with a defect in the number of 
endodermal cells. Thus, the levels of endoderm proliferation and cell death in the Hz 
mutant should also be evaluated at an early stage such as E8.5. 
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Chapter IV 
Final Remarks 
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Final Remarks 
  
 BMP signalling is essential for many aspects of development, including 
mesoderm formation and ectoderm patterning. In the DE, several studies have 
identified roles of BMP signalling in the formation of ventral gut organs 34-38.  
 We proposed that BMP signalling acts as a global cue in ventral patterning of 
the DE (Figure 1.3). The findings presented in this study are in accordance with the 
hypothesis. However, many questions remain before it can be confirmed. For instance, 
BMP signalling may be essential for the initial invagination of the AIP as suggested 
previously73, or it may also be required for ventral migration of the lateral DE and 
consequent ventral closure of the gut tube. The role of BMP in organogenesis is also 
still unclear. Is it required for specification, proliferation, maintenance of identity? 
Perhaps it is required for distinct processes depending on the organ in question. 
Challenges in the future are to uncover new targets of BMP during endoderm 
development. Human Embryonic Stem cell derived endoderm could be used in order to 
identify which genes are downstream targets of BMP.  
 A global understanding of how BMP signalling acts during dorsal-ventral 
patterning of the DE will facilitate the development of more efficient protocols that 
better emulate the development of organs like the lungs, liver or the pancreas, bringing 
us one step forward into the exciting field of in vitro organogenesis74. 
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